185 related articles for article (PubMed ID: 19577615)
1. bFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells.
Berdiaki A; Nikitovic D; Tsatsakis A; Katonis P; Karamanos NK; Tzanakakis GN
Biochim Biophys Acta; 2009 Oct; 1790(10):1258-65. PubMed ID: 19577615
[TBL] [Abstract][Full Text] [Related]
2. Regulation of hyaluronan and versican deposition by growth factors in fibrosarcoma cell lines.
Berdiaki A; Zafiropoulos A; Fthenou E; Katonis P; Tsatsakis A; Karamanos NK; Tzanakakis GN
Biochim Biophys Acta; 2008 Feb; 1780(2):194-202. PubMed ID: 17980161
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone (PTH) peptides through the regulation of hyaluronan metabolism affect osteosarcoma cell migration.
Berdiaki A; Datsis GA; Nikitovic D; Tsatsakis A; Katonis P; Karamanos NK; Tzanakakis GN
IUBMB Life; 2010 May; 62(5):377-86. PubMed ID: 20222016
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan stimulates pancreatic cancer cell motility.
Cheng XB; Kohi S; Koga A; Hirata K; Sato N
Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359
[TBL] [Abstract][Full Text] [Related]
5. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.
Kouvidi K; Berdiaki A; Nikitovic D; Katonis P; Afratis N; Hascall VC; Karamanos NK; Tzanakakis GN
J Biol Chem; 2011 Nov; 286(44):38509-38520. PubMed ID: 21914806
[TBL] [Abstract][Full Text] [Related]
6. Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis.
Kouvidi K; Berdiaki A; Tzardi M; Karousou E; Passi A; Nikitovic D; Tzanakakis GN
Biochim Biophys Acta; 2016 Apr; 1860(4):814-24. PubMed ID: 26825774
[TBL] [Abstract][Full Text] [Related]
7. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
8. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
Udabage L; Brownlee GR; Nilsson SK; Brown TJ
Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction.
Shimabukuro Y; Terashima H; Takedachi M; Maeda K; Nakamura T; Sawada K; Kobashi M; Awata T; Oohara H; Kawahara T; Iwayama T; Hashikawa T; Yanagita M; Yamada S; Murakami S
J Cell Physiol; 2011 Mar; 226(3):809-21. PubMed ID: 20857427
[TBL] [Abstract][Full Text] [Related]
10. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
[TBL] [Abstract][Full Text] [Related]
11. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S
Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
[TBL] [Abstract][Full Text] [Related]
13. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D
Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072
[TBL] [Abstract][Full Text] [Related]
14. Elevated level of ambient glucose stimulates the synthesis of high-molecular-weight hyaluronic acid by human mesangial cells. The involvement of transforming growth factor beta1 and its activation by thrombospondin-1.
Yevdokimova NY
Acta Biochim Pol; 2006; 53(2):383-93. PubMed ID: 16733556
[TBL] [Abstract][Full Text] [Related]
15. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells.
Li Y; Li L; Brown TJ; Heldin P
Int J Cancer; 2007 Jun; 120(12):2557-67. PubMed ID: 17315194
[TBL] [Abstract][Full Text] [Related]
16. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.
Zhu H; Mitsuhashi N; Klein A; Barsky LW; Weinberg K; Barr ML; Demetriou A; Wu GD
Stem Cells; 2006 Apr; 24(4):928-35. PubMed ID: 16306150
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.
Hiraga T; Ito S; Nakamura H
Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan/RHAMM interactions in mesenchymal tumor pathogenesis: role of growth factors.
Kouvidi K; Nikitovic D; Berdiaki A; Tzanakakis GN
Adv Cancer Res; 2014; 123():319-49. PubMed ID: 25081535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
